- Home
- KIO vs TMCI Comparison
KIO vs TMCI Comparison
Compare KIO & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIO
- TMCI
- Stock Information
- Founded
- KIO 2011
- TMCI 2014
- Country
- KIO United States
- TMCI United States
- Employees
- KIO 2400
- TMCI N/A
- Industry
- KIO Investment Managers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KIO Finance
- TMCI Health Care
- Exchange
- KIO Nasdaq
- TMCI Nasdaq
- Market Cap
- KIO 522.7M
- TMCI 435.3M
- IPO Year
- KIO N/A
- TMCI 2021
- Fundamental
- Price
- KIO $12.49
- TMCI $7.47
- Analyst Decision
- KIO
- TMCI Hold
- Analyst Count
- KIO 0
- TMCI 5
- Target Price
- KIO N/A
- TMCI $8.60
- AVG Volume (30 Days)
- KIO 136.5K
- TMCI 422.2K
- Earning Date
- KIO 01-01-0001
- TMCI 08-07-2025
- Dividend Yield
- KIO 10.82%
- TMCI N/A
- EPS Growth
- KIO N/A
- TMCI N/A
- EPS
- KIO N/A
- TMCI N/A
- Revenue
- KIO N/A
- TMCI $213,751,000.00
- Revenue This Year
- KIO N/A
- TMCI $10.63
- Revenue Next Year
- KIO N/A
- TMCI $9.44
- P/E Ratio
- KIO N/A
- TMCI N/A
- Revenue Growth
- KIO N/A
- TMCI 7.67
- 52 Week Low
- KIO $10.52
- TMCI $4.54
- 52 Week High
- KIO $13.59
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- KIO 44.91
- TMCI 71.10
- Support Level
- KIO $12.26
- TMCI $6.80
- Resistance Level
- KIO $12.70
- TMCI $7.78
- Average True Range (ATR)
- KIO 0.10
- TMCI 0.53
- MACD
- KIO -0.03
- TMCI 0.14
- Stochastic Oscillator
- KIO 39.47
- TMCI 88.12
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.